JPWO2021066175A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021066175A5 JPWO2021066175A5 JP2021551622A JP2021551622A JPWO2021066175A5 JP WO2021066175 A5 JPWO2021066175 A5 JP WO2021066175A5 JP 2021551622 A JP2021551622 A JP 2021551622A JP 2021551622 A JP2021551622 A JP 2021551622A JP WO2021066175 A5 JPWO2021066175 A5 JP WO2021066175A5
- Authority
- JP
- Japan
- Prior art keywords
- delivery system
- active pharmaceutical
- conjugate
- hydrophobic compound
- pharmaceutical ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025059920A JP2025094276A (ja) | 2019-10-03 | 2025-03-31 | 膀胱の粘膜下組織への医薬品有効成分の経粘膜的送達システム、医薬組成物、及び膀胱疾患処置剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019183082 | 2019-10-03 | ||
| JP2019183082 | 2019-10-03 | ||
| PCT/JP2020/037640 WO2021066175A1 (ja) | 2019-10-03 | 2020-10-02 | 膀胱の粘膜下組織への医薬品有効成分の経粘膜的送達システム |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025059920A Division JP2025094276A (ja) | 2019-10-03 | 2025-03-31 | 膀胱の粘膜下組織への医薬品有効成分の経粘膜的送達システム、医薬組成物、及び膀胱疾患処置剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2021066175A1 JPWO2021066175A1 (cg-RX-API-DMAC7.html) | 2021-04-08 |
| JPWO2021066175A5 true JPWO2021066175A5 (cg-RX-API-DMAC7.html) | 2023-10-02 |
| JP7660066B2 JP7660066B2 (ja) | 2025-04-10 |
Family
ID=75338281
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021551622A Active JP7660066B2 (ja) | 2019-10-03 | 2020-10-02 | 膀胱の粘膜下組織への医薬品有効成分の経粘膜的送達システム |
| JP2025059920A Pending JP2025094276A (ja) | 2019-10-03 | 2025-03-31 | 膀胱の粘膜下組織への医薬品有効成分の経粘膜的送達システム、医薬組成物、及び膀胱疾患処置剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025059920A Pending JP2025094276A (ja) | 2019-10-03 | 2025-03-31 | 膀胱の粘膜下組織への医薬品有効成分の経粘膜的送達システム、医薬組成物、及び膀胱疾患処置剤 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20220370630A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4039279A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7660066B2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021066175A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023034903A1 (en) * | 2021-09-01 | 2023-03-09 | 3Helix, Inc. | Systems and methods for detecting fibrosis |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6083933A (en) * | 1999-04-19 | 2000-07-04 | Stellar International Inc. | Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution |
| US20080306022A1 (en) | 2005-10-12 | 2008-12-11 | Kenji Miyamoto | Agent for Applying to Mucosa and Method for the Production Thereof |
| US10098962B2 (en) * | 2013-07-10 | 2018-10-16 | Seikagaku Corporation | Glycosaminoglycan derivative and method for producing same |
| US20150250717A1 (en) * | 2014-03-06 | 2015-09-10 | Taris Biomedical Llc | Drug delivery systems and methods for treatment of bladder cancer with gemcitabine |
| US10350236B2 (en) * | 2015-01-09 | 2019-07-16 | Seikagaku Corporation | Chondroitin sulfate derivative and agent for treating bladder diseases |
| JP7067229B2 (ja) | 2018-04-17 | 2022-05-16 | 信越化学工業株式会社 | 反応性ケイ素含有基を有するポリマーおよびその製造方法 |
-
2020
- 2020-10-02 JP JP2021551622A patent/JP7660066B2/ja active Active
- 2020-10-02 US US17/762,279 patent/US20220370630A1/en active Pending
- 2020-10-02 WO PCT/JP2020/037640 patent/WO2021066175A1/ja not_active Ceased
- 2020-10-02 EP EP20871804.9A patent/EP4039279A4/en active Pending
-
2025
- 2025-03-31 JP JP2025059920A patent/JP2025094276A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5349318B2 (ja) | ステロイド類の高分子結合体 | |
| EP4450487A3 (en) | Lipids for lipid nanoparticle delivery of active agents | |
| JP2018524339A5 (cg-RX-API-DMAC7.html) | ||
| JP5856069B2 (ja) | 新規なシチジン系代謝拮抗剤の高分子誘導体 | |
| EP2898881B1 (en) | Compositions comprising supramolecular complexes of polyanionic polymers and spermidine for use in the treatment of periodontum and damaged oral tissue | |
| TW201815786A (zh) | 苯并咪唑衍生物((S)-4-(5,7-二氟唍-4-基氧基)-N,N,2-三甲基-1H-苯并[d]]咪唑-6-甲醯胺)之酸加成鹽 | |
| RU2008126305A (ru) | Новый пептид | |
| JP2008543854A5 (cg-RX-API-DMAC7.html) | ||
| JP2018531962A5 (cg-RX-API-DMAC7.html) | ||
| MXPA02005536A (es) | Acidos aminopropilfosfinicos novedosos. | |
| CA2637765A1 (en) | Benzamide and heteroarene derivatives | |
| GEP20156209B (en) | Linaclotide-containing formulations for oral administration | |
| JPWO2008010463A1 (ja) | コンブレタスタチン類の高分子結合体 | |
| EE200200245A (et) | Farmatseutiline kompositsioon, mis sisaldab tolterodiini ja selle kasutamine | |
| MX2025013218A (es) | Lipidos para usarse en formulaciones de nanoparticulas de lipido | |
| JP2021529818A (ja) | 治療用デンドリマー | |
| MX2025005209A (es) | Compuestos lipídicos y usos de los mismos | |
| CN110612143A (zh) | 抗微生物化合物、组合物及其用途 | |
| MX2025015196A (es) | Amida y éster mixtos que contienen lípidos para usarse en nanopartículas lipídicas | |
| WO2005085294A1 (ja) | ヒアルロン酸−メトトレキサート結合体 | |
| JP2025118775A5 (cg-RX-API-DMAC7.html) | ||
| CN120731082A (zh) | 新多功能寡肽 | |
| MX2022011242A (es) | Inmunomodulación de o-het/aril azálidos. | |
| TW202133882A (zh) | 肽與多醣的新共軛物 | |
| JP4467888B2 (ja) | アロエ−エモジン誘導体と腫瘍性病理学の治療におけるその使用 |